| EMODEGEN vs Steve | 18–15 | 54.55% |
| EMODEGEN vs Kazuya | 15–13 | 53.57% |
| EMODEGEN vs Reina | 20–8 | 71.43% |
| EMODEGEN vs Bryan | 18–7 | 72.00% |
| EMODEGEN vs King | 11–8 | 57.89% |
| EMODEGEN vs Jin | 10–8 | 55.56% |
| EMODEGEN vs Law | 8–8 | 50.00% |
| EMODEGEN vs Devil Jin | 5–11 | 31.25% |
| EMODEGEN vs Hwoarang | 9–6 | 60.00% |
| EMODEGEN vs Jun | 10–4 | 71.43% |
| EMODEGEN vs Dragunov | 8–5 | 61.54% |
| EMODEGEN vs Lee | 9–4 | 69.23% |
| EMODEGEN vs Alisa | 6–6 | 50.00% |
| EMODEGEN vs Raven | 5–7 | 41.67% |
| EMODEGEN vs Lidia | 6–6 | 50.00% |
| EMODEGEN vs Yoshimitsu | 4–7 | 36.36% |
| EMODEGEN vs Feng | 6–4 | 60.00% |
| EMODEGEN vs Lili | 7–3 | 70.00% |
| EMODEGEN vs Lars | 6–2 | 75.00% |
| EMODEGEN vs Leroy | 4–4 | 50.00% |
| EMODEGEN vs Victor | 5–3 | 62.50% |
| EMODEGEN vs Jack-8 | 4–3 | 57.14% |
| EMODEGEN vs Eddy | 5–2 | 71.43% |
| EMODEGEN vs Heihachi | 3–4 | 42.86% |
| EMODEGEN vs Xiaoyu | 5–1 | 83.33% |
| EMODEGEN vs Asuka | 5–1 | 83.33% |
| EMODEGEN vs Claudio | 3–3 | 50.00% |
| EMODEGEN vs Leo | 4–1 | 80.00% |
| EMODEGEN vs Nina | 4–1 | 80.00% |
| EMODEGEN vs Kuma | 4–0 | 100.00% |
| EMODEGEN vs Clive | 4–0 | 100.00% |
| EMODEGEN vs Anna | 2–2 | 50.00% |
| EMODEGEN vs Paul | 2–1 | 66.67% |
| EMODEGEN vs Zafina | 2–0 | 100.00% |
| EMODEGEN vs Azucena | 0–2 | 0.00% |
| EMODEGEN vs Shaheen | 1–0 | 100.00% |
Limitations
This data is often requested to give insight into which characters you have more trouble with than others, but it is not particularly helpful for that. The main issue is that it is heavily skewed by how strong the opponents you play are.
For example, this data suggests my worst matchup is clearly vs Reina, but that's just because most of those games are vs Yagami.
There is a way to account for this being worked on. The central idea is to assign each matchup a rating vs you which adjusts based on the result, much like the regular rating but also based on the rating of each player. With this, it would give a better summary of how well you perform vs each character.
In the meantime, this page is here to present the data as requested.